Patents by Inventor Karin Sandager Nielsen

Karin Sandager Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
    Patent number: 7842817
    Abstract: This invention relates to novel 2-amino benzimidazole derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: January 10, 2006
    Date of Patent: November 30, 2010
    Assignee: Neurosearch A/S
    Inventors: Ulrik Svane Sørensen, Lene Teuber, Dan Peters, Dorte Strøbæk, Tina Holm Johansen, Karin Sandager Nielsen, Palle Christophersen
  • NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS
    Publication number: 20100280087
    Abstract: This invention relates to novel 2-amino benzimidazole derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Application
    Filed: July 8, 2010
    Publication date: November 4, 2010
    Inventors: Ulrik Svane Sørensen, Lene Teuber, Dan Peters, Dorte Strøbæk, Tina Holm Johansen, Karin Sandager Nielsen, Palle Christophersen
  • 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
    Patent number: 7737167
    Abstract: This invention relates to novel 2-amino benzimidazole derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: June 15, 2010
    Assignee: Neurosearch A/S
    Inventors: Ulrik Svane Sørensen, Lene Teuber, Dan Peters, Dorte Strøbæk, Tina Holm Johansen, Karin Sandager Nielsen, Palle Christophersen
  • ARYL PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROPSYCHIATRY DISORDERS
    Publication number: 20100087445
    Abstract: This invention provides novel aryl piperazine derivatives represented by Formula (I) having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D3, 5HT1A and 5-HT2A receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders, incl. schizophrenia.
    Type: Application
    Filed: October 12, 2007
    Publication date: April 8, 2010
    Applicant: Universita degli Studi di Siena
    Inventors: Giuseppe Campiani, Stefania Butini, Caterina Fattorusso, Silvia Franceschini, Irene Zia Thale, Karin Sandager Nielsen, Jørgen Scheel-Krüeger, Lars Siim Madsen
  • Novel Aryl Piperazine Derivatives With Medical Utility
    Publication number: 20090238761
    Abstract: This invention provides novel aryl piperazine derivatives having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D3, D2-like and 5-HT2 receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders incl. schizophrenia.
    Type: Application
    Filed: January 2, 2006
    Publication date: September 24, 2009
    Applicant: Universita Degli Studi Di Siena
    Inventors: Giuseppe Campiani, Stefania Butini, Caterina Fattorusso, Francesco Trotta, Silvia Franceschini, Meri De Angelis, Karin Sandager Nielsen
  • 2-(Phenylamino) Benzimidazole Derivatives and Their Use as Modulators of Small- Conductance Calcuim-Activated Potassium Channels
    Publication number: 20090076106
    Abstract: This invention relates to novel 2-(phenylamino)benzimidazole derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Application
    Filed: June 21, 2006
    Publication date: March 19, 2009
    Applicant: NEUROSEARCH A/S
    Inventors: Ulrik Svane Sorensen, Lene Teuber, Dan Peters, Dorte Strobaek, Tina Holm Johansen, Karin Sandager Nielsen, Palle Christophersen
  • Novel 2-Amino Benzimidazole Derivatives and Their Use As Modulators Of Small-Conductance Calcium-Activated Potassium Channels
    Publication number: 20080200529
    Abstract: This invention relates to novel 2-amino benzimidazole derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Application
    Filed: January 10, 2006
    Publication date: August 21, 2008
    Applicant: NEURO SEARCH A/S
    Inventors: Ulrik Svane Sorensen, Lene Teuber, Dan Peters, Dorte Strobaek, Tina Holm Johansen, Karin Sandager Nielsen, Palle Christophersen
  • Benzothiazine derivatives, their preparation and use
    Patent number: 7199118
    Abstract: This invention relates to novel benzothiazine derivatives of Formula I useful as modulators of the AMPA sensitive glutamate receptors, pharmaceutical compositions comprising such compounds and their use in therapy.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: April 3, 2007
    Assignee: NeuroSearch A/S
    Inventors: Alex Haahr Gouliaev, Morgens Larsen, Thomas Varming, Claus Mathiesen, Tina Holm Johansen, Karin Sandager Nielsen, Barbara Hartz, Jorgen Scheel-Kruger
  • Adenosine AA receptor antangonists combined with neurotrophic activity compounds in the treatment of Parkinson's disease
    Patent number: 7160899
    Abstract: This invention relates to the use of the combined action of a compound with neurotrophic activity and an adenosine A2A receptor antagonist for the treatment of Parkinson's disease.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: January 9, 2007
    Assignee: Neurosearch A/S
    Inventors: Dan Peters, Lars Christian B. Rønn, Karin Sandager Nielsen
  • Novel benzothiazine derivatives, their preparation and use
    Publication number: 20040242571
    Abstract: This invention relates to novel benzothiazine derivatives of Formula I useful as modulators of the AMPA sensitive glutamate receptors, pharmaceutical compositions comprising such compounds and their use in therapy.
    Type: Application
    Filed: March 15, 2004
    Publication date: December 2, 2004
    Inventors: Alex Haahr Gouliaev, Morgens Larsen, Thomas Varming, Claus Mathiesen, Tina Holm Johansen, Karin Sandager Nielsen, Barbara Hartz, Jorgen Scheel-Kruger
  • Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
    Publication number: 20040097540
    Abstract: This invention relates to the use of the combined action of a compound with neurotrophic activity and an adenosine A2A receptor antagonist for the treatment of Parkinson's disease.
    Type: Application
    Filed: October 2, 2003
    Publication date: May 20, 2004
    Inventors: Dan Peters, Lars Christian B. Ronn, Karin Sandager Nielsen